Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
20.42 USD | +5.75% | +3.07% | -25.63% |
Apr. 15 | Goldman Sachs Cuts Veracyte Price Target to $28 From $32, Maintains Buy Rating | MT |
Feb. 26 | Morgan Stanley Trims Veracyte's Price Target to $21 From $22, Keeps Underweight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.63% | 1.48B | |
-19.07% | 10.82B | |
+48.28% | 3.25B | |
-32.87% | 2.11B | |
-14.15% | 2.08B | |
+19.62% | 1.02B | |
-2.62% | 733M | |
-30.95% | 391M | |
-43.78% | 383M | |
+29.03% | 332M |
- Stock Market
- Equities
- VCYT Stock
- News Veracyte, Inc.
- Goldman Sachs Cuts Veracyte Price Target to $28 From $32, Maintains Buy Rating